• Je něco špatně v tomto záznamu ?

The Expanding Mycovirome of Aspergilli

JL. Battersby, DA. Stevens, RHA. Coutts, V. Havlíček, JL. Hsu, G. Sass, I. Kotta-Loizou

. 2024 ; 10 (8) : . [pub] 20240817

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/bmc24018005

Grantová podpora
R01 HL157414 NHLBI NIH HHS - United States
NHLBI R01HL157414-01 NIH HHS - United States
LUAUS24214 Ministry of Education, Youth and Sports of the Czech Republic LUAUS24214, Czech-US INTER-EXCELLENCE program, Secondary Metabolism of Intracellular Pathogens, and CZ.02.01.01/00/22_008/0004597, Talking microbes - understanding microbial interactions within

Mycoviruses are viruses that infect fungi and are widespread across all major fungal taxa, exhibiting great biological diversity. Since their discovery in the 1960s, researchers have observed a myriad of fungal phenotypes altered due to mycoviral infection. In this review, we examine the nuanced world of mycoviruses in the context of the medically and agriculturally important fungal genus, Aspergillus. The advent of RNA sequencing has revealed a previous underestimate of viral prevalence in fungi, in particular linear single-stranded RNA viruses, and here we outline the diverse viral families known to date that contain mycoviruses infecting Aspergillus. Furthermore, we describe these novel mycoviruses, highlighting those with peculiar genome structures, such as a split RNA dependent RNA polymerase gene. Next, we delineate notable mycovirus-mediated phenotypes in Aspergillus, in particular reporting on observations of mycoviruses that affect their fungal host's virulence and explore how this may relate to virus-mediated decreased stress tolerance. Furthermore, mycovirus effects on microbial competition and antifungal resistance are discussed. The factors that influence the manifestation of these phenotypes, such as temperature, fungal life stage, and infection with multiple viruses, among others, are also evaluated. In addition, we attempt to elucidate the molecular mechanisms that underpin these phenotypes, examining how mycoviruses can be targets, triggers, and even suppressors of RNA silencing and how this can affect fungal gene expression and phenotypes. Finally, we highlight the potential therapeutic applications of mycoviruses and how, in an approach analogous to bacteriophage therapy, their ability to produce hypovirulence in Aspergillus might be used to attenuate invasive aspergillosis infections in humans.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24018005
003      
CZ-PrNML
005      
20241016081951.0
007      
ta
008      
241008s2024 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jof10080585 $2 doi
035    __
$a (PubMed)39194910
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Battersby, Josephine L $u Department of Life Sciences, Imperial College London, London SW7 2AZ, UK $u Department of Clinical, Pharmaceutical and Biological Science, University of Hertfordshire, Hatfield AL10 9AB, UK
245    14
$a The Expanding Mycovirome of Aspergilli / $c JL. Battersby, DA. Stevens, RHA. Coutts, V. Havlíček, JL. Hsu, G. Sass, I. Kotta-Loizou
520    9_
$a Mycoviruses are viruses that infect fungi and are widespread across all major fungal taxa, exhibiting great biological diversity. Since their discovery in the 1960s, researchers have observed a myriad of fungal phenotypes altered due to mycoviral infection. In this review, we examine the nuanced world of mycoviruses in the context of the medically and agriculturally important fungal genus, Aspergillus. The advent of RNA sequencing has revealed a previous underestimate of viral prevalence in fungi, in particular linear single-stranded RNA viruses, and here we outline the diverse viral families known to date that contain mycoviruses infecting Aspergillus. Furthermore, we describe these novel mycoviruses, highlighting those with peculiar genome structures, such as a split RNA dependent RNA polymerase gene. Next, we delineate notable mycovirus-mediated phenotypes in Aspergillus, in particular reporting on observations of mycoviruses that affect their fungal host's virulence and explore how this may relate to virus-mediated decreased stress tolerance. Furthermore, mycovirus effects on microbial competition and antifungal resistance are discussed. The factors that influence the manifestation of these phenotypes, such as temperature, fungal life stage, and infection with multiple viruses, among others, are also evaluated. In addition, we attempt to elucidate the molecular mechanisms that underpin these phenotypes, examining how mycoviruses can be targets, triggers, and even suppressors of RNA silencing and how this can affect fungal gene expression and phenotypes. Finally, we highlight the potential therapeutic applications of mycoviruses and how, in an approach analogous to bacteriophage therapy, their ability to produce hypovirulence in Aspergillus might be used to attenuate invasive aspergillosis infections in humans.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
655    _2
$a přehledy $7 D016454
700    1_
$a Stevens, David A $u California Institute for Medical Research, San Jose, CA 95128, USA $u Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
700    1_
$a Coutts, Robert H A $u Department of Clinical, Pharmaceutical and Biological Science, University of Hertfordshire, Hatfield AL10 9AB, UK $1 https://orcid.org/0000000193507203
700    1_
$a Havlíček, Vladimír $u Institute of Microbiology of the Czech Academy of Sciences, Videnska 1083, 142 00 Prague, Czech Republic $u Department of Analytical Chemistry, Palacky University, 17. Listopadu 2, 779 00 Olomouc, Czech Republic $1 https://orcid.org/0000000286147059 $7 jx20041110004
700    1_
$a Hsu, Joe L $u Department of Medicine, Division of Pulmonary, Allergy and Critical Care Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA
700    1_
$a Sass, Gabriele $u California Institute for Medical Research, San Jose, CA 95128, USA
700    1_
$a Kotta-Loizou, Ioly $u Department of Life Sciences, Imperial College London, London SW7 2AZ, UK $u Department of Clinical, Pharmaceutical and Biological Science, University of Hertfordshire, Hatfield AL10 9AB, UK $1 https://orcid.org/0000000332776359
773    0_
$w MED00203318 $t Journal of fungi $x 2309-608X $g Roč. 10, č. 8 (2024)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/39194910 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20241008 $b ABA008
991    __
$a 20241016081947 $b ABA008
999    __
$a ok $b bmc $g 2196434 $s 1229956
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2024 $b 10 $c 8 $e 20240817 $i 2309-608X $m Journal of fungi $n J Fungi (Basel) $x MED00203318
GRA    __
$a R01 HL157414 $p NHLBI NIH HHS $2 United States
GRA    __
$a NHLBI R01HL157414-01 $p NIH HHS $2 United States
GRA    __
$a LUAUS24214 $p Ministry of Education, Youth and Sports of the Czech Republic LUAUS24214, Czech-US INTER-EXCELLENCE program, Secondary Metabolism of Intracellular Pathogens, and CZ.02.01.01/00/22_008/0004597, Talking microbes - understanding microbial interactions within
LZP    __
$a Pubmed-20241008

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...